These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10144664)
21. By the numbers. Top 20 pharmaceutical companies. Ranked by U.S. sales, April 2003 through March 2004. Moon S Mod Healthc; 2004 Aug; 34(33):40. PubMed ID: 15356990 [No Abstract] [Full Text] [Related]
22. High drug costs seem to keep getting higher. Ackerman W J Ark Med Soc; 2005 Apr; 101(10):293. PubMed ID: 15839313 [No Abstract] [Full Text] [Related]
23. What strategy can do for technology. The five rules of technology leadership. Clark KB Harv Bus Rev; 1989; 67(6):94-8. PubMed ID: 10303994 [No Abstract] [Full Text] [Related]
24. Brand management: only the strong survive. Willey D J Bus Strategy; 1993; 14(3):30-3. PubMed ID: 10126459 [TBL] [Abstract][Full Text] [Related]
25. The promise and peril of direct-to-consumer prescription drug promotion on the Internet. Hall TS DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476 [No Abstract] [Full Text] [Related]
26. Using specialty advertising in a niche marketing plan. Schwisow CR Med Group Manage J; 1992; 39(3):32-3. PubMed ID: 10118999 [TBL] [Abstract][Full Text] [Related]
27. Response to Maubach and Hoek's paper on GP attitudes to DTCA. Toop L; Richards D; Dowell T N Z Med J; 2005 Jun; 118(1217):U1543. PubMed ID: 15980914 [No Abstract] [Full Text] [Related]
29. Drug abuse testing: issues and opportunities. Gardner J; Mehl PE Hosp Technol Ser; 1988 May; 7(12):1-11. PubMed ID: 10304476 [No Abstract] [Full Text] [Related]
30. From product line to disease management--easing the transition. Stanfill P J Oncol Manag; 1997; 6(5):27-30. PubMed ID: 10175096 [TBL] [Abstract][Full Text] [Related]
31. Winning strategies for academic centers. Morris DE Health Care Strateg Manage; 1988 Jul; 6(7):14-6. PubMed ID: 10302674 [TBL] [Abstract][Full Text] [Related]
33. Why so glum? Toward a fair balance of competitive interests in direct-to-consumer advertising and the well-being of the mentally ill consumers it targets. Lenhardt E Health Matrix Clevel; 2005; 15(1):165-204. PubMed ID: 16092771 [No Abstract] [Full Text] [Related]
34. How to sell to a segmented market. Swenson CA J Bus Strategy; 1988; 9(1):18-22. PubMed ID: 10313820 [No Abstract] [Full Text] [Related]
35. Competitive strategies for the next generation of managed care. Lathrop JP Healthc Forum J; 1996; 39(2):36-8, 52-5. PubMed ID: 10156627 [No Abstract] [Full Text] [Related]
36. Quick response technology: the key to outstanding growth. Knorr RO; Neuman JL J Bus Strategy; 1992; 13(5):61-4. PubMed ID: 10121464 [No Abstract] [Full Text] [Related]
37. Drug samples are meant for advertising. Thawani V Issues Med Ethics; 2001; 9(3):91. PubMed ID: 16334483 [No Abstract] [Full Text] [Related]
38. Consumerism as a branding opportunity. Treash M; Adams R Manag Care Q; 1998; 6(4):26-32. PubMed ID: 10185775 [TBL] [Abstract][Full Text] [Related]
39. The fine art of positioning. DiMingo E J Bus Strategy; 1988; 9(2):34-8. PubMed ID: 10303386 [No Abstract] [Full Text] [Related]
40. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Rosenthal M J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]